BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11034814)

  • 1. Novel chemotherapeutic agents in colorectal cancer.
    Napier MP; Ledermann JA
    Eur J Surg Oncol; 2000 Sep; 26(6):605-10. PubMed ID: 11034814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of advanced colorectal cancers after failure of a treatment with fluoropyrimidine].
    Misset JL
    Rev Prat; 1997 Jun; 47(12 Spec No):S29-35. PubMed ID: 9248091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.
    Schmoll HJ
    Semin Oncol; 2002 Oct; 29(5 Suppl 15):34-9. PubMed ID: 12422306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: colorectal cancer chemotherapy.
    Gill S; Thomas RR; Goldberg RM
    Aliment Pharmacol Ther; 2003 Oct; 18(7):683-92. PubMed ID: 14510741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug clinics. How I treat. II. Therapeutic approaches to metastatic colorectal cancer].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):318-21. PubMed ID: 9713208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental chemotherapeutic agents for the treatment of colorectal carcinoma.
    O'Reilly S; Rowinsky EK
    Hematol Oncol Clin North Am; 1997 Aug; 11(4):721-58. PubMed ID: 9257153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of new agents in the treatment of colorectal cancer.
    Köhne CH; Bruce C; Folprecht G; Audisio R
    Surg Oncol; 2004; 13(2-3):75-81. PubMed ID: 15572089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Absence of cross resistance between an irinotecan plus cisplatin combination and raltitrexed (ZD1694) in two patients with advanced colorectal cancer].
    Sato A; Kurihara M; Matsukawa M; Yamazaki T; Shimada K; Endo W; Yamazaki T; Nakamachi M
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):617-21. PubMed ID: 10791007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing face of chemotherapy in colorectal cancer.
    Waters J; Cunningham D
    Br J Cancer; 2001 Jan; 84(1):1-7. PubMed ID: 11139304
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing the fight against advanced colorectal cancer: new and future treatment options.
    Bleiberg H
    Anticancer Drugs; 1998 Jan; 9(1):18-28. PubMed ID: 9491788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin: a new therapeutic option in colorectal cancer.
    Cvitkovic E; Bekradda M
    Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Lloyd Jones M; Hummel S; Bansback N; Orr B; Seymour M
    Health Technol Assess; 2001; 5(25):1-128. PubMed ID: 11990245
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic therapy for colorectal cancer: focus on newer chemotherapy and novel agents.
    O'Neil BH
    Semin Radiat Oncol; 2003 Oct; 13(4):441-53. PubMed ID: 14586833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
    Ducreux M; Louvet C; Bekradda M; Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):47-53. PubMed ID: 9609108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer.
    Van Triest B; Peters GJ
    Oncology; 1999 Oct; 57(3):179-94. PubMed ID: 10545786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment options for advanced colorectal cancer.
    Rougier P; Mitry E
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.